Skip to content

EVENTS

Below please find our upcoming and past events. Click an event for further detail.


  • Join Claris Biotherapeutics for an event featuring key opinion leader (KOL) John Affeldt, MD (Loma Linda University Health), who will…
    Join vTv Therapeutics for a virtual KOL event featuring leading T1D experts Schafer Boeder, MD (Paradigm Clinical Research, University of…
    Join enGene for a webinar that will provide greater detail on the preclinical data supporting the incorporation of its surfactant…
    Join PDS Biotechnology for a virtual key opinion leader (KOL) event featuring Jonathan M. Hernandez, M.D. (Investigator, Surgical Oncology Program,…
    Join Arrowhead Pharmaceuticals for an R&D webinar to highlight interim clinical data from the Phase 1/2a study of ARO-MAPT for…
    Join Faeth Therapeutics for a virtual key opinion leader (KOL) event featuring Marcus Goncalves, MD, PhD (NYU Langone Health &…
    Join Compugen for a virtual key opinion leader (KOL) event featuring Oladapo Yeku, MD, PhD, FACP (Harvard Medical School, Massachusetts…
    Join Agomab Therapeutics for a virtual management and key opinion leader (KOL) event on the positive topline data from the…
  • Join Sagimet Biosciences for a virtual event featuring key opinion leader (KOL) Julie Harper, MD, Founding Director and past President…
    Join ProQR Therapeutics for a virtual investor and analyst educational event featuring Gideon Hirschfield, MA (Oxon), MB BChir (Cantab), FRCP,…
    Join Legend Biotech for a virtual KOL event featuring Leyla Shune, MD (Franciscan Health) and Marco Davila, MD, PhD (Roswell…
    Join Quince Therapeutics for a virtual key opinion leader (KOL) event featuring PH-ILD experts Aaron B. Waxman, MD, PhD (Brigham…
    Join CAMP4 Therapeutics for a virtual Analyst Day featuring presentations and Q&A led by CAMP4’s executive leadership team, with participation…
    Join Rapport Therapeutics for a virtual key opinion leader (KOL) event featuring Gary Sachs, MD (Massachusetts General Hospital, Harvard Medical School) and Mauricio…
    Details to follow.
    Join Corbus Pharmaceuticals for a conference call to discuss topline data for CANYON‑1, a Phase 1b study of CRB‑913 for…

    Contact Us
    to Get Started